NATURE’S SUNSHINE PRODUCTS, INC. Deferred Income Tax Liabilities, Net
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Deferred Income Tax Liabilities, Net of $886.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-06
- 2026-06-30: Deferred Income Tax Liabilities, Net $886.00K.
- 2026-03-31: Deferred Income Tax Liabilities, Net $799.00K.
- 2025-12-31: Deferred Income Tax Liabilities, Net $954.00K.
- 2025-09-30: Deferred Income Tax Liabilities, Net $1.07M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $886.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $799.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $954.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.07M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.01M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $1.16M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $1.01M 10-K · filed 2026-03-10 |
| 2024-09-30 | $1.35M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.16M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.51M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.40M 10-K · filed 2025-03-11 |
| 2023-09-30 | $1.25M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.20M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $936.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.44M 10-K · filed 2024-03-12 |
| 2022-09-30 | $1.22M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.21M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.13M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.57M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.57M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.60M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.24M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.39M 10-K · filed 2022-03-08 |
| 2020-09-30 | $2.05M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.65M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.47M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.66M 10-K · filed 2021-03-10 |
| 2019-09-30 | $1.50M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.56M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.55M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.56M 10-K · filed 2020-03-11 |
| 2018-09-30 | $763.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $714.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $783.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $770.00K 10-K · filed 2019-03-08 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |